Professional Documents
Culture Documents
PDF Botulinum Toxin Procedures in Cosmetic Dermatology Series 4Th Edition Alastair Carruthers Ebook Full Chapter
PDF Botulinum Toxin Procedures in Cosmetic Dermatology Series 4Th Edition Alastair Carruthers Ebook Full Chapter
https://textbookfull.com/product/lasers-and-lights-procedures-in-
cosmetic-dermatology-series-4th-edition-george-j-hruza/
https://textbookfull.com/product/chemical-peels-procedures-in-
cosmetic-dermatology-series-3rd-edition-suzan-obagi/
https://textbookfull.com/product/aesthetic-procedures-nurse-
practitioners-guide-to-cosmetic-dermatology-beth-haney/
https://textbookfull.com/product/botulinum-toxin-therapy-scott-m-
whitcup-editor/
Botulinum Toxin Treatment What Everyone Should Know
Bahman Jabbari
https://textbookfull.com/product/botulinum-toxin-treatment-what-
everyone-should-know-bahman-jabbari/
https://textbookfull.com/product/textbook-of-cosmetic-
dermatology-5th-edition-robert-baran/
https://textbookfull.com/product/dermatologic-surgery-and-
cosmetic-procedures-in-primary-care-practice-jonathan-kantor/
https://textbookfull.com/product/discourses-of-perfection-
representing-cosmetic-procedures-and-beauty-products-in-uk-
lifestyle-magazines-1st-edition-anne-mette-hermans/
https://textbookfull.com/product/arbitrage-theory-in-continuous-
time-oxford-finance-series-4th-edition-bjork/
Botulinum Toxin
PROCEDURES IN COSMETIC
DERMATOLOGY
FOURTH EDITION
Edited by
2
Edinburgh London New York Oxford Philadelphia St Louis Sydney Toronto 2018
3
Table of Contents
Cover image
Title Page
Series page
Copyright
Video contents
Series preface
Preface
List of contributors
Acknowledgments
Dedication
Further reading
4
Developed indications for onabotulinumtoxinA
Commentary
Acknowledgment
Further reading
Serendipitous discovery
FDA approval
Further reading
Manufacturing
Formulation
Mechanism of action
Immunogenicity
Approvals
Acknowledgment
References
Further reading
5 AbobotulinumtoxinA
References
Further reading
6 Basic science
Introduction
Properties of incobotulinumtoxinA
5
Clinical performance of incobotulinumtoxinA
Conclusion
References
Further reading
7 Basic science
Introduction
Mechanism of action
Immunogenicity of Myobloc
Side effects
Conclusion—future outlook
References
Introduction
Further reading
Introduction
Mechanism of action
Compositional differences
Dosing
Efficacy
Duration of action
Safety
Resistance
6
Storage
Conclusion
Further reading
Topical daxibotulinumtoxinA
Further reading
Introduction
Conclusions
Further reading
Introduction
Reconstitution diluents
Conclusion
Further reading
14 Benzyl alcohol
Introduction
Saline with benzyl alcohol: early evidence of anesthetic efficacy and historical concerns
7
References
15 Glabella
Introduction
Anatomy
Dosing
Special considerations
Conclusion
Further reading
16 Modulation of eyebrow position and shape by treatment with Neuromodulators and fillers
Introduction
The consultation
Treatment
Fillers
References
Introduction
Side effects
Injection techniques
Types of botox
Botox dosing
Treatment of scars
Conclusion
Further reading
Introduction
Preoperative assessment
Treatment
Adjunctive treatments
8
Complications
Conclusion
Further reading
Introduction
Periorbital aging
General considerations
Adverse events
Conclusion
Further reading
Introduction
Zygomaticus complex
Risorius
Conclusion
Further reading
Anatomy
Differences in the use of botulinum toxin for the upper and lower face
Target muscle
Conclusion
Further reading
Introduction
9
Anatomy
Treatment techniques
References
History
Anatomy
Bruxism
Treatment method
Complications
Conclusion
References
Further reading
Conclusion
Further reading
Brow ptosis
Neocollagenesis
Injectables
Skin tightening
Topical agents
Summary
10
References
Further reading
Epidemiology
Quality of life
Axillary hyperhidrosis
Future directions
Further reading
27 Palmoplantar hyperhidrosis
Introduction
Patient evaluation
General considerations
Anesthesia
Injection technique
Complications
Conclusion
Further reading
Introduction
Conclusions
References
Further reading
Index
11
Series page
Procedures in Cosmetic Dermatology
Series Editor: Jeffrey S. Dover MD, FRCPC, FRCP
Associate Editor: Murad Alam MD, MSCI
Chemical Peels
Second edition
ISBN 978-1-4377-1924-6
Second edition
ISBN 978-1-4377-0739-7
Body Contouring
Bruce E. Katz MD and Neil S. Sadick MD, FAAD, FAACS, FACP, FACPh
ISBN 978-1-4377-0739-7
Murad Alam MD, MSCI and Jeffrey S. Dover MD, FRCPC, FRCP
ISBN 978-1-4160-5960-8
Botulinum Toxin
Fourth edition
Alastair Carruthers MA, BM, BCh, FRCPC, FRCP(Lon) and Jean Carruthers MD, FRCSC, FRC(Ophth),
FASOPRS
ISBN 978-0-323-47659-1
Fourth edition
Jean Carruthers MD, FRCSC, FRC(Ophth), FASOPRS and Alastair Carruthers MA, BM, BCh, FRCPC,
FRCP(Lon)
ISBN 978-0-323-47658-4
12
Body Shaping: Skin Fat Cellulite
Jeffrey Orringer MD, Jeffrey S. Dover MD, FRCPC, FRCP and Murad Alam MD, MSCI
ISBN 978-0323321976
Cosmeceuticals
Third edition
Zoe Diana Draelos MD, Murad Alam MD, MSCI and Jeffrey S. Dover MD, FRCPC, FRCP
ISBN 978-0-323-29869-8
Fourth edition
ISBN 978-0-323-48006-2
Photodynamic Therapy
Second edition
Mitchel P. Goldman MD
ISBN 978-1-4160-4211-2
Liposuction
ISBN 978-1-4160-2208-4
Scar Revision
Kenneth A. Arndt MD
ISBN 978-1-4160-3131-4
Hair Transplantation
ISBN 978-1-4160-3104-8
Blepharoplasty
ISBN 978-1-4160-2996-0
For Elsevier
Content Strategist: Belinda Kuhn
Content Development Specialist: Humayra Rahman Khan
Project Manager: Srividhya Vidhyashankar
Design: Miles Hitchen
Illustration Manager: Nichole Beard
13
Copyright
No part of this publication may be reproduced or transmitted in any form or by any means, electronic
or mechanical, including photocopying, recording, or any information storage and retrieval system,
without permission in writing from the publisher. Details on how to seek permission, further
information about the Publisher's permissions policies and our arrangements with organizations such
as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website:
www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the
Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience
broaden our understanding, changes in research methods, professional practices, or medical treatment
may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating
and using any information, methods, compounds, or experiments described herein. In using such
information or methods they should be mindful of their own safety and the safety of others, including
parties for whom they have a professional responsibility.
With respect to any drug or pharmaceutical products identified, readers are advised to check the most
current information provided (i) on procedures featured or (ii) by the manufacturer of each product to
be administered, to verify the recommended dose or formula, the method and duration of
administration, and contraindications. It is the responsibility of practitioners, relying on their own
experience and knowledge of their patients, to make diagnoses, to determine dosages and the best
treatment for each individual patient, and to take all appropriate safety precautions.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume
any liability for any injury and/or damage to persons or property as a matter of products liability,
negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas
contained in the material herein.
ISBN: 978-0-323-47659-1
E-ISBN: 978-0-323-48007-9
Printed in China
14
15
Video contents
Video 6 Bocouture Injection
Jürgen Frevert, MD, Gerhard Sattler, MD
Video 8 Neuronox
Kyle Koo-II Seo, MD
Video 15 Glabella
Derek H. Jones, MD
Video 16 Brow Shaping
Alastair Carruthers, MD
Video 17 Frontalis and HFL
Joel L. Cohen, MD
Video 18.1 Crow's Feet
Jean Carruthers, MD
Video 18.2 Lower Eyelid
Alastair Carruthers, MD
Video 19 Technique Demonstrating Pretarsal Injection to Widen Vertical Palpebral Aperture
Shannon Humphrey, MD, Steven Fagien, MD
Video 20.1 Bunny Lines
Jean Carruthers, MD
Video 20.2 Gummy Smile
Jean Carruthers, MD
Video 21.1 Depressor Anguli Oris and Mentalis (1)
Alastair Carruthers, MD
Video 21.2 Depressor Anguli Oris and Mentalis (2)
Jean Carruthers, MD
Video 21.3 Depressor Anguli Oris and Mentalis (3)
Jean Carruthers, MD
Video 26.1 Hyperhidrosis: Palmar Injection Technique
Dee Anna Glaser, MD, Adam R. Mattox, MD
Video 26.2 Hyperhidrosis: Axillary HH Treatment and Starch Iodine Test
Dee Anna Glaser, MD, Adam R. Mattox, MD
16
Series preface
Much has changed since the first edition of this series. Non-invasive and minimally invasive cosmetic
procedures, as pioneered by dermatologists, have become increasingly adopted by physicians and well-
accepted by patients. Cosmetic dermatologic surgery procedures have been refined and improved.
Interventions have become more effective, and also safer and more tolerable with increasing benefit:
risk ratios. Combination cosmetic regimens that include multiple procedure types have been shown to
achieve results comparable to those with more invasive procedures. And new devices and technologies
continue to be introduced.
And how best to keep up with these advances and to ensure your offerings are state of the art and at
the cutting edge? The newest edition of the Procedures in Cosmetic Dermatology series keeps you
there, and for those starting out in the field these texts quickly introduce you and bring you to the state
of the art. Each book in this series is designed to quickly impart basic skills as well as advanced
concepts in an easy-to-understand manner. We focus not on theory but on how-to. Our expert book
editors and chapter authors will guide you through the learning process efficiently, so you can soon get
back to treating patients.
The authors are leading dermatologists in the field. Dermatologists' role in cosmetic medicine has
continued to expand. Research has revealed that primary care physicians and the general public view
dermatologists as the experts in less invasive cosmetic procedures. A nationwide advanced fellowship
program in cosmetic dermatologic surgery has been initiated to train the next generation of
dermatologists to the highest standards.
What has not changed is physicians' need for clear, concise, and current direction on procedure
techniques. Physicians need to be proficient in the latest methods for enhancing appearance and
concealing the visible signs of aging.
To that end, we hope that you, our reader, find the books enjoyable and educational.
We thank our many contributors and wish you well on your journey of discovery.
Jeffrey S. Dover MD, FRCPC, FRCP, Murad Alam MD, MSCI
17
Series preface first edition
Although dermatologists have been procedurally inclined since the beginning of the specialty,
particularly rapid change has occurred in the past quarter century. The advent of frozen section
technique and the golden age of Mohs skin cancer surgery have led to the formal incorporation of
surgery within the dermatology curriculum. More recently technological breakthroughs in minimally
invasive procedural dermatology have offered an aging population new options for improving the
appearance of damaged skin.
Procedures for rejuvenating the skin and adjacent regions are actively sought by our patients.
Significantly, dermatologists have pioneered devices, technologies, and medications, which have
continued to evolve at a startling pace. Numerous major advances, including virtually all cutaneous
lasers and light-source-based procedures, botulinum exotoxin, soft tissue augmentation, dilute
anesthesia liposuction, leg vein treatments, chemical peels, and hair transplants, have been invented or
developed and enhanced by dermatologists. Dermatologists understand procedures, and we have
special insight into the structure, function, and working of skin. Cosmetic dermatologists have made
rejuvenation accessible to risk-averse patients by emphasizing safety and reducing operative trauma.
No specialty is better positioned than dermatology to lead the field of cutaneous surgery while meeting
patient needs.
As dermatology grows as a specialty, an ever-increasing proportion of dermatologists will become
proficient in the delivery of different procedures. Not all dermatologists will perform all procedures,
and some will perform very few, but even the less procedurally directed among us must be well versed
in the details to be able to guide and educate our patients. Whether you are a skilled dermatologic
surgeon interested in further expanding your surgical repertoire, a complete surgical novice wishing to
learn a few simple procedures, or somewhere in between, this book and this series are for you.
The volume you are holding is one of a series entitled Procedures in Cosmetic Dermatology. The
purpose of each book is to serve as a practical primer on a major topic area in procedural dermatology.
If you want to make sure you find the right book for your needs, you may wish to know what this
book is and what it is not. It is not a comprehensive text grounded in theoretical underpinnings. It is
not exhaustively referenced. It is not designed to be a completely unbiased review of the world's
literature on the subject. At the same time, it is not an overview of cosmetic procedures that describes
these in generalities without providing enough specific information to actually permit someone to
perform the procedures. Importantly, it is not so heavy that it can serve as a doorstop or a shelf filler.
What this book and this series offer is a step-by-step, practical guide to performing cutaneous
surgical procedures. Each volume in the series has been edited by a known authority in that subfield.
Each editor has recruited other equally practical-minded, technically skilled, hands-on clinicians to
write the constituent chapters. Most chapters have two authors to ensure that different approaches and
a broad range of opinions are incorporated. On the other hand, the two authors and the editors also
collectively provide a consistency of tone. A uniform template has been used within each chapter so
that the reader will be easily able to navigate all the books in the series. Within every chapter, the
authors succinctly tell it like they do it. The emphasis is on therapeutic technique; treatment methods
are discussed with an eye to appropriate indications, adverse events, and unusual cases. Finally, this
book is short and can be read in its entirety on a long plane ride. We believe that brevity paradoxically
results in greater information transfer because cover-to-cover mastery is practicable.
We hope you enjoy this book and the rest of the books in the series and that you benefit from the
many hours of clinical wisdom that have been distilled to produce it. Please keep it nearby, where you
can reach for it when you need it.
18
Jeffrey S. Dover MD, FRCPC, FRCP, Murad Alam MD, MSCI
19
Preface
So why should we expect you to be interested in a new volume on the cosmetic use of
neuromodulators? Well, right there is a reason. Earlier editions talked about botulinum toxin, whereas
now we are discussing neuromodulators—referring to the use of these materials to modulate the
subject rather than to achieve the result by controlled paralysis. Partly this is due to our better
understanding of the method of action of the botulinum toxins, but also it reflects the way we are using
the neurotoxins now.
Since the third edition in 2012 there have been major advances in the use of neuromodulators, and
we have attempted to incorporate these into this volume without being too biased. We have continued
the policy begun in volume 3 of asking each of the companies involved in the commercial production of
neuromodulators to write a chapter on their product(s), avoiding comparisons as much as possible.
These chapters contain much useful information to be discovered, and we hope you will enjoy them as
well as the other chapters in this volume. We think that we have avoided too much of a commercial
bias.
The chapter on the newer Revance products (RT002) shows a significant change from the third
edition, when we thought they would be producing a commercial topical toxin, whereas now they
appear to be focusing on extending the duration of effect of the toxin. We advise you not to give up on
the topical toxin, which we believe to have a future in both the cosmetic and therapeutic worlds, and we
expect that the other companies with expertise in this area will be producing neuromodulators with
unique properties.
Similarly, the cosmetic use has continued to change, and we hope you will appreciate the new
chapters. New authors are giving you their expertise and their new knowledge. It is fascinating to see
how something that we thought was settled (the use of botulinum neurotoxin type A in the brow) has
changed so much! In addition, the use has expanded into new areas, as well as the new methods of
using the botulinum neurotoxin (BoNT).
Overall, our understanding of the clinical use of BoNT, as well as the products themselves, has really
changed this area. We hope that you will agree with us after reading this well-produced volume. Enjoy!
Alastair Carruthers MA, BM, BCh, FRCPC, FRCP(Lon), Jean Carruthers MD, FRCSC, FRC (OPHTH), FASOPRS
20
List of contributors
The editor(s) acknowledge and offer grateful thanks for the input of all previous editions' contributors,
without whom this new edition would not have been possible.
Murad Alam MD, MSCI, Professor of Dermatology, Otolaryngology, and Surgery; Chief, Section of
Cutaneous and Aesthetic Surgery, Northwestern University, Chicago, IL, USA
GeeYoung Bae MD, Director of Rose Clinic, Clinical Professor in the Department of Dermatology of
Ulsan University, College of Medicine, University of Ulsan, Seoul, Korea
Katie Beleznay MD, FRCPC, FAAD, Clinical Instructor, Department of Dermatology and Skin
Science, University of British Columbia, Vancouver, BC, Canada
Jeanette M. Black MD, Dermatologist, Skin Care and Laser Physicians of Beverly Hills, Los Angeles,
CA, USA
Andrew Blitzer MD, DDS, Professor Emeritus of Otolaryngology/Head and Neck Surgery, Columbia
University, College of Physicians and Surgeons; Adjunct Professor of Neurology, Icahn School of
Medicine at Mt. Sinai; Director, NY Center for Voice and Swallowing Disorders; Co-Founder and
Director of Research, ADN International, New York, NY, USA
Jennifer B. Mancuso MD, Dermatology Resident, Henry Ford Hospital, Detroit, MI, USA
Mitchell F. Brin MD
Senior Vice President, Global Drug Development,
Chief Scientific Officer, BOTOX®, Allergan, Inc., Irvine, CA;
Professor of Neurology, University of California, Irvine, CA, USA
Letícia Cardoso Secco MD, Volunteer Dermatologist, Hospital do Servidor Público Municipal de São
Paulo, Brazil
Alastair Carruthers MA, BM, BCh, FRCPC, FRCP(Lon), Clinical Professor, Department of
Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
Jean Carruthers MD, FRCSC, FRC (OPHTH), FASOPRS, Clinical Professor, Department of
Ophthalmology and Visual Science, University of British Columbia, Vancouver, BC, Canada
Joel L. Cohen MD
Director, AboutSkin Dermatology and DermSurgery, Englewood;
Associate Clinical Professor, Department of Dermatology, University of Colorado, Denver, CO, USA
21
Adjunct Associate Professor of Dermatology
Brown Medical School, Providence, RI, USA
Steven Fagien MD, FACS, Private Practice, Aesthetic Eyelid Plastic Surgery, Boca Raton, FL, USA
Timothy C. Flynn MD
Clinical Professor, Department of Dermatology, University of North Carolina, Chapel Hill, NC;
Medical Director, Cary Skin Center, Cary, NC, USA
Jürgen Frevert PhD, Head of Botulinum Toxin Research, Merz Pharmaceuticals GmbH, Potsdam,
Germany
Conor J. Gallagher PhD, Senior Medical Director, Facial Aesthetics, Medical Affairs, Allergan, Plc,
Irvine, CA, USA
Dee Anna Glaser MD, Professor and Vice Chairman; Director Cosmetic and Laser Surgery,
Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO, USA
Richard G. Glogau MD, Clinical Professor of Dermatology, University of California San Francisco,
San Francisco, CA, USA
Greg J. Goodman MBBS, FACD, MD, Associate Professor, Monash University; Chief of Surgery, Skin
and Cancer Foundation Inc., Carlton, VIC, Australia
Pearl E. Grimes MD, Director, Vitiligo and Pigmentation Institute of Southern California; Clinical
Professor, Division of Dermatology, David Geffan School of Medicine, University of California, Los
Angeles, CA, USA
Bhushan Hardas MD, MBA, US Head of Research & Development and Vice President, Merz
Pharmaceuticals, LLC, Greensboro, NC, USA
Shannon Humphrey MD, FRCPC, FAAD, Clinical Assistant Professor, Director of CME, Department
of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
Matthias Imhof MD, Dermatologist, Aesthetic Dermatology Department, Medico Palais, Bad Soden,
Germany
Derek H. Jones MD, Associate Clinical Professor, Dermatology, David Geffen School of Medicine,
University of California, Los Angeles; Dermatologist, Skin Care and Laser Physicians of Beverly Hills,
Los Angeles, CA, USA
Dr. Michael Z. Lerner, Assistant Professor of Otolaryngology, Albert Einstein College of Medicine,
Bronx, NY, USA
Austin Liu MD, Dermatology & Mohs Surgery Center, Doylestown and Sellersville, PA, USA
Ian A. Maher MD, FAAD, Assistant Professor, Department of Dermatology, Saint Louis University,
St. Louis, MO, USA
Adam R. Mattox DO, MS, Physician Research Fellow, Department of Dermatology, Saint Louis
University School of Medicine, Saint Louis, MO, USA
Gary D. Monheit MD, FAAD, FACS, Private Practice, Total Skin and Beauty Dermatology Center, PC;
Associate Clinical Professor, Departments of Dermatology and Ophthalmology, University of Alabama
at Birmingham, Birmingham, AL, USA
Jasmine O. Obioha MD, Resident, Department of Dermatology, Icahn School of Medicine at Mount
Sinai, New York, NY, USA
22
David M. Ozog MD, FAAD, Director of Cosmetic Dermatology; Vice-Chair of Operations, Division
of Mohs and Dermatological Surgery, Henry Ford Hospital, Detroit, MI, USA
Amit A. Patel MD, Otolaryngologist, ENT Allergy Group, Shrewsbury, NJ, USA
Roman G. Rubio MD, MBA, Senior Vice President of Clinical Development, Revance Therapeutics,
Inc., Newark, CA, USA
Thomas E. Rohrer MD
Clinical Associate Professor of Dermatology, The Warren Alpert Medical School of Brown University,
Providence, RI;
Director of Mohs Fellowship, SkinCare Physicians, Chestnut Hill, MA, USA
Neil S. Sadick MD, FAAD, FAACS, FACP, FACPh, Clinical Professor, Weill Cornell Medical College,
Cornell University; Sadick Dermatology and Research Group, New York, NY, USA
Nazanin Saedi, Director, Laser Surgery and Cosmetic Dermatology, Thomas Jefferson University
Hospitals, Philadelphia, PA, USA
Kyle Koo-II Seo MD, PhD, Clinical Associate Professor, Dermatology, Seoul National University
College of Medicine; Director, Dermatology, Modelo Clinic, Seoul, Korea
Kevin C. Smith MD, FRCPC [Derm], Private Practice, Niagara Falls, ON, Canada
Nowell Solish MD, FRCPC, Assistant Professor of Dermatology, University of Toronto, ON, Canada
Ada R. Trindade de Almeida MD, Dermatologist, Dermatologic Clinic, Hospital do Servidor Público
Municipal de São Paulo and private office, São Paulo, Brazil
Jacob M. Waugh MD, Illustris Pharmaceuticals, Inc., Palo Alto, CA, USA
Mara Weinstein Velez MD, Dermatologist, SkinCare Physicians of Chestnut Hill, Chestnut Hill, MA,
USA
Naissan O. Wesley MD
Clinical Instructor, Medicine, Division of Dermatology, David Geffen School of Medicine, University of
California, Los Angeles, CA, USA;
Dermatologist and Dermatologic Surgeon, Skin Care and Laser Physicians of Beverly Hills, Los
Angeles, CA, USA
23
Acknowledgments
Looking back over the past 30 years of our involvement in the clinical use of botulinum toxin there are
very many people who have supported and encouraged us. The first to be mentioned, of course, is Alan
Scott, MD, who has been consistently generous with his educational efforts, his clinical information, his
research results and, with his wife Ruth, hospitality. Sitting on their deck above Mill Valley looking
towards the Golden Gate Bridge we have learned more about botulinum toxin than in any lecture hall.
From the early days of oculinum and then botox we have had fascinating and enlightening
discussions with Mitchell Brin, MD, and Andrew Blitzer, MD, both from Columbia. The early group of
us who formed a core set of advisers for Allergan (our advice was not always well received and usually
was ahead of its time) consisted of Andrew Blitzer, MD, Richard Glogau, MD, Nicholas Lowe, MD,
Arnold Klein, MD, and the two of us. These sessions and teleconferences set the stage for the future
education and development of the cosmetic use of botulinum toxin and were a major learning
experience for us all. The basic science which Roger Aoki, PhD, of Allergan Inc., provided to us gave a
solid basis for our understanding of how the toxin works and the meaning of both basic and clinical
studies.
In more recent years we have had valuable assistance from many individuals, many of whom are
coauthors in this book. We have greatly appreciated the contributions of many of our international
colleagues such as Ada Trindade de Almeida, MD, Francisco Perez Atamoros, MD, and Koenraad de
Boulle, MD. To all of the authors of this text, we salute you! We are so grateful for the hard work you
have put into this volume and the tolerance you have shown when faced with yet more unreasonable
editorial demands. The proof of your labors and dedication is easily seen between the covers of this
book.
Any list of acknowledgments would not be complete without recognizing the people who actually do
the work to make it all work: our staff and our patients. Our patients have been so very tolerant,
especially in the beginning when we did not fully understand the potential benefits as well as the
pitfalls of the cosmetic use of botulinum toxin. Our staff have been consistently supportive and helpful
(finding photographs from the vaguest descriptions, following up results good and bad, keeping things
running smoothly so we could go off and deliver another lecture). We could not have done it without
you!
Finally, our friends and family have accepted the fact that we might or might not be in a given place
at a given time, that we spend more time thinking about them in airports than actually talking to them,
that our crazy idea has generated a crazy life. Many thanks to you all!
Alastair Carruthers MA, BM, BCh, FRCPC, FRCP(Lon), Jean Carruthers MD, FRCSC, FRC (OPHTH), FASOPRS
24
Dedication
Firstly, and most importantly, we dedicate this volume to our sons and their families. Our
sons were young when the botulinum toxin story began and they have regarded the efforts
of their parents to cope with this accidental discovery with tolerance and increasing pride
over the years. We have appreciated the support and encouragement they have given us.
The love they have given us means we are indeed fortunate.
We have been fortunate to have an amazing series of mentors during our careers, Alan
Scott and Barrie Jay for Jean and Ted Tromovitch, Sam Stegman, Rick Glogau and Stuart
Maddin for us both. The interest and imagination stirred by these individuals has been
crucial.
Finally we have been fortunate to work with outstanding people over the years in our
various offices as well as at the American Society for Dermatologic Surgery. They have all
been a part of our story and have helped to create our careers and hence the volume
which you are holding. Thanks to all of them!
Alastair Carruthers MA, BM, BCh, FRCPC, FRCP(Lon), Jean Carruthers MD, FRCSC, FRC (OPHTH), FASOPRS
25
1
• Botulinum toxins will reduce and prevent the release of substances exocytosed by SNARE proteins.
• Reduction of SNARE function may have therapeutic implications for autonomic, sensory, and motor
parts of the nervous system.
• Reduction of SNARE function can also reduce the release of inflammatory mediators, such as
substance P, calcitonin gene-related peptide, and glutamate.
• Bioengineered toxins may allow precise localization and decrease of exocytosed proteins, such as
hormones.
Introduction
Since the 1970s, when Alan Scott introduced botulinum neurotoxin A as a therapeutic agent, the
number of different uses for this drug has increased exponentially. In the 1950s Arnold Burgen and
Vernon Brooks, at McGill, discovered that botulinum toxin presynaptically blocked the release of
acetylcholine from motor nerve terminals, thus weakening muscle strength by chemical denervation.
Brooks also reported that botulinum toxin could possibly be used therapeutically. The observation that
tetanus and botulinum toxins blocked the exocytosis of acetylcholine was further refined with the
discovery that these toxins enzymatically degraded different portions of the soluble N-ethylmaleimide-
sensitive factor attachment protein receptor (SNARE) proteins. Alan Scott's original work using
botulinum toxin to weaken muscle for the correction of strabismus and then blepharospasm led others
to begin to investigate the toxins for use with other dystonias and hyperfunctional muscular disorders.
26
The original observations of Kerner that patients with botulism had dry mouth and eyes suggested
that the toxin might be used to control hypersecretory states. With the knowledge that the autonomic
nervous system also depended on acetylcholine as the neurotransmitter, it seemed even more likely
that botulinum toxin could be used to control disorders of this system. Clinical trials have shown
efficacy in autonomic disorders, such as hyperhidrosis, sialorrhea, and Frey syndrome.
A number of trials for hyperfunctional muscular disorders, such as cervical dystonia and spasticity,
showed a dramatic reduction of pain, even greater than the reduction of muscle function. Our trials of
toxin use for cosmetic indications revealed a number of individuals whose migraine headaches
disappeared. These and other studies revealed a pattern that seemed to indicate that the toxin had a
role in pain syndromes. Other studies then showed that, even in cases of postherpetic neuralgia, pain
could be decreased or eliminated. This clinical information led to the discovery that inflammatory
mediators, such as calcitonin gene-related peptide (CGRP), substance P, and glutamate, are also
released by SNARE proteins. The toxin will reduce or eliminate the release locally of inflammatory
mediators that have the effect of lowering central nervous system pain thresholds and thereby causing
central sensitization. Toxin treatment of chronic migraine headaches was recently European Union (EU)
and US Food and Drug Administration (FDA) approved after extensive clinical trials.
The newest change to potential toxin treatment has been the ability to change the molecule. The
binding site of the molecule has been altered chemically to add specific ligands. This allows a toxin to
be created that has an affinity for sensory but not motor neurons, autonomic neurons, and even certain
excretory glands. Keith Foster, of Syntaxin, has described making a specific ligand for growth hormone
secretory cells in the pituitary gland. Growth hormone is also secreted with a SNARE-related exocytosis
and therefore can be modulated with targeted specific botulinum toxin. This treatment could be used
for patients with acromegaly. Other glandular secretions should be studied in this new paradigm for
hypersecretory control.
Given the already wide range of clinical applications of botulinum toxin, it is not surprising that
other avenues are being pursued. Intraarticular injections of botulinum toxin are also under study as a
way of relieving joint pain from osteoarthritis and chronic pain after joint replacement among others.
The utility of toxin in temporomandibular myofascial and joint pain is also being investigated.
Both crocodile tear syndrome and first bite syndrome, both consequences of aberrant nerve
regeneration similar to Frey syndrome, have been successfully treated with botulinum toxin injection.
One interesting avenue of research involves botulinum toxin in the treatment of cancer and the side
effects of current treatments of cancer. Botox has been shown to reduce vesicle transport in breast
cancer cell lines; further research is ongoing to see if this has an effect on cancer growth. Research in a
mouse model has shown that preradiation treatment of the salivary glands with botulinum toxin
conferred protection. A phase I trial is ongoing to see if this carries over to humans.
Further work continues on elucidating the clinical efficacies of the different subtypes of botulinum
toxin. Currently all the type A toxin used clinically is subtype A1. Kaji et al. described the clinical
efficacy of the A2 subtype and found it was 1.5 times that of onabotulinumtoxinA (subtype A1) with
similar time course and less spread of its action to a neighboring muscle. Further studies into this
subtype and other subtypes are currently underway.
In addition to its use for neurogenic overactive bladder, studies have also suggested a role for
botulinum toxin in the treatment of interstitial cystitis and chronic bladder pain, as well as chronic
prostatitis. Studies suggest that intravesical botulinum injection reduces bladder pain and increases
bladder capacity and can reduce inflammation.
The following material will in greater depth describe the use of botulinum toxins for the
management of disorders of efferent nerves and muscular hyperfunction; afferent nerves, pain
disorders, and inflammatory conditions; autonomic nervous system disorders; and glandular
hypersecretion (Box 1.1).
Box 1.1
Therapeutic uses of botulinum toxins
I. Hyperfunctional muscular use
1. Dystonia
27
a. Cervical dystonia
b. Blepharospasm
c. Oromandibular dystonia
d. Spasmodic dysphonia
f. Foot dystonia
g. Musician's dystonia
h. Facial dystonia
i. Meige syndrome
4. Strabismus
5. Esotropia/exotropia
6. Nystagmus
9. Myoclonus
3. Sialorrhea/sialocele/drooling
4. Rhinitis
5. UES/LES achalasia
28
6. Neurogenic hyperactive bladder
7. Frey syndrome
8. Anal fissures
9. Vaginismus/anismus
1. Tension headaches
2. Migraine headaches
3. Temporomandibular disorders/bruxism
4. Myofascial pain
5. Postherpetic neuralgia
6. Arthritis
7. Trigeminal neuralgia
1. Growth hormone/acromegaly
LES, Lower esophageal sphincter; UES, upper esophageal sphincter.
29
Another random document with
no related content on Scribd:
CHAPTER XXIII.
DICK MERRIWELL’S NERVE.
“Take your dog away, sir! Take him away, or I’ll shoot him!”
A clear, boyish voice rang through the lobby of the hotel.
“Black” Ben Elrich, one of the best known sporting men and
gamblers of the State, had just passed along the corridor,
accompanied by two companions of his ilk and a huge, fierce-looking
mastiff.
Dick Merriwell, running lightly into the corridor, had been stopped by
the dog, which suddenly whirled on him and drove him back several
steps, seeming on the point of leaping at the lad’s throat.
For some unknown reason the dog seemed to have taken a sudden
dislike to the boy, and, as he growled and showed his teeth, he
looked dangerous, indeed.
Immediately on being driven back by the dog, Dick had drawn a
revolver, which he held ready for use. Elrich uttered an exclamation
of astonishment and anger.
“Stop Rex, Dan!” he exclaimed. “Get hold of him, Tom! He’ll chew up
the kid!”
“He won’t do that,” returned the boy instantly, “for I shall shoot him in
his tracks if you don’t take care of him.”
The men accompanying Elrich leaped forward, one on either side of
the dog, and grasped the huge animal by the collar. Barely had they
seized him thus when the animal tried to make a spring at the throat
of the boy, and it took their combined strength to hold him in check.
“It’s a good thing for him that you grabbed him just when you did,”
exclaimed the cool youngster. “I knew he was going to jump, and I’d
sure shot him.”
“Why, confound you, kid!” growled Elrich, as the men pulled the dog
back; “how dare you pull a revolver on my dog?”
“I’d pull a gun on your dog just as quick as I would on you,” returned
Dick. “I don’t consider your dog much better than you, sir, though it’s
right likely he is some.”
“That is my brother!” said Frank Merriwell to Berlin Carson.
“Well, he’s a hummer!” exclaimed the rancher’s son, in deep
admiration.
“Let’s sift in and take part in that,” breathed Hodge eagerly.
“Wait,” advised Frank. “I want to see what that black-whiskered
fellow will try to do, and I also wish to see how Dick handles himself.”
The big sporting man was angered by the words of the ready-
tongued youngster, and he growled:
“You’re an insolent brat, and you need to be taught a lesson!”
“I scarcely think it would be to my advantage to have you for an
instructor,” returned the lad. “Anything I’d learn of you would be an
injury to me.”
Now, “Black” Elrich had killed his man, and was generally respected
and feared by the dangerous element of the town, and it was a novel
experience for him to have anybody fearlessly face him and talk to
him in such a manner.
“I’d begin by wringing your neck!” he asserted. “It’s just what you
deserve!”
“And I’d shoot you so full of holes that you’d make a first-class sieve,
which would be just what you deserve,” retorted Dick Merriwell, his
cheeks burning.
“If you were a man——”
“Don’t let that bother you, mister. I can take care of myself. Keep
your hands out of sight, or I may think you’re reaching for a shooting-
iron, in which case I shall not hesitate to break your elbow with a
bullet.”
“Why, you don’t know how to handle such a toy as that!”
“Don’t I? Perhaps not, but I’ve had a few lessons from a man who is
your master with any kind of a weapon.”
“Meaning you?” asked Carson of Merriwell.
“Meaning an old Indian by the name of Joe Crowfoot,” explained
Frank, in a low tone. “Crowfoot taught him to shoot rifle, revolver,
and bow and arrow, and he’s a credit to his tutor.”
“Well, you’re a mere kid, and you have no right to carry concealed
weapons,” said Elrich.
“And you’re a mere ruffian, who has less right to carry concealed
weapons,” flung back Dick. “I know you’ve got a gun on your hip, and
I shall ask to have you searched if you make complaint against me.”
“That’s the stuff!” muttered Carson. “He’s sized up Black Elrich in a
minute, and he’s bluffing the most dangerous man in Denver.”
The eyes of Bart Hodge glowed with satisfaction. Bart had never
spoken a word of praise to Dick, but there was about the boy much
that awakened his admiration.
“Where’s your father?” demanded the gambler, furiously. “I’ll call on
him and see if he——”
“You’ll never call on him,” Dick declared, “for you’re not going in his
direction. He’s up there.”
The boy pointed upward, and Black Ben thought he meant that his
father was above in the hotel.
“What’s his name?” demanded the man. “I’ll go up to him at once.”
“Spare yourself the trouble, for it’s higher than you’ll ever get. He is
dead.”
For a moment the man was taken aback, and then his fiery temper
flamed up.
“You’re some runaway brat who thinks——”
“Stop!” exclaimed the lad. “That is the second time you have called
me a brat, and I warn you not to do so again! I am not a brat, and I
——”
At this point one of the men who had pulled the dog away stepped in
by a side door and clutched the wrist of the boy, giving it a wrench
and twisting the revolver away with his other hand.
It was done in a twinkling, and Black Elrich sprang forward. At the
same moment Merriwell advanced, with his two companions at his
heels.
But, before one of them could interfere, out through the same door
strode a tall form that caught the man who had clutched Dick,
grasped him by the neck, gave him a swing and a throw that flung
him fifteen feet away, sprawling on the tiled floor of the corridor.
Behind this tall figure came another, about the shoulders of which
was a dirty red blanket, perchance the most remarkable figure ever
seen in the Hotel Metropole.
Both were Indians, but the first, almost six feet tall and straight as an
arrow, was dressed in the garments of civilization. The other,
however, must have attracted attention anywhere in Denver from his
half-savage attire. The first was young and handsome; the second
was old and wrinkled.
“Joe!” cried the boy, as he saw the old Indian.
“Ugh!” said Old Joe Crowfoot.
With a furious exclamation, Black Elrich started to whip out a
revolver; but his wrist was clutched from behind by fingers that
seemed like bands of steel, and he was held fast, while a quiet voice
spoke in his ear:
“I wouldn’t try that trick, sir! You have been monkeying with my
brother, and I shall have to call you to account if he is molested
further.”
Elrich was trembling with the intensity of his rage.
“Let go!” he panted, as he looked round.
A pair of calm brown eyes looked into his with utter fearlessness,
and Frank Merriwell spoke again:
“I shall not let go until you realize the folly of trying to do any
shooting here. Two friends are with me, besides the two who have
just interfered to protect my brother, and we can do some shooting
when it is necessary.”
Elrich became cool at once.
“I see that you have the advantage, sir,” he said; “and I will not be
foolish enough to draw. I give you the word of Ben Elrich, and my
word is good, whatever else may be said about me.”
Instantly Frank released the wrist of the man.
“I accept your word of honor,” he said.
“But let me tell you,” said the baffled gambler, “that I’ll not forget what
has happened here. You say that boy is your brother? Well, you had
better take care of him.”
“I have an idea that, given a fair show, he can take care of himself.
He proved quite able to do so until one of your friends caught him at
a disadvantage by a trick. It took two men to get the best of a boy of
thirteen, which is something I feel certain you will not be proud of.”
“Who are you?” demanded Elrich. “I may wish to see you again.”
“My name is Frank Merriwell, and you will find me right here at this
hotel, for a day or two, at least.”
“Frank Merriwell!” muttered Black Ben, starting a trifle, and looking at
Merry with added interest. “And this is your brother?”
“Exactly.”
Then the gambler turned and looked at Dick, as if fixing the features
of the boy upon his memory, so that he would know the lad again,
anywhere and under any circumstances.
CHAPTER XXIV.
MERRY’S CHUMS.
When the chagrined and defeated Elrich, together with his worthy
companion, had departed from the corridor, Frank Merriwell lost no
time in offering his hand to the handsome young Indian who had
intervened in time to save Dick from further molestation.
“Swiftwing!” Merry exclaimed, in deep satisfaction. “I am glad to see
you.”
The face of the Indian remained grave, but deep in his eyes shone a
light that told his unspeakable emotions.
“Frank Merriwell,” he said, in a deep, well-modulated voice, “once I
thought never to look on your face again, but fate has permitted us to
meet once more.”
Frank thought of the farewell message written him by the Carlisle
Indian almost a year before, in which Swiftwing had expressed the
affection and admiration that his tongue had never spoken. Their
hand lingered in contact, and then Hodge offered to shake.
Bart had never liked Swiftwing much, but now he was truly glad to
see the young Indian.
Old Joe Crowfoot stood there like a mummy, his keen black eyes
watching all that took place.
“It’s a great piece of luck,” said Merry. “You are the man to fill out our
baseball-team.”
“It is not luck,” said Swiftwing. “Crowfoot came to me and told me
you had been searching for me.”
“Then I have Crowfoot to thank?”
“Old Joe, him tell you he bring Swiftwing,” said the old fellow quietly.
“And you have kept your promise.”
“Not for you,” Old Joe asserted. “For Dick.”
“Dick, he——”
“He make Old Joe promise.”
“But I thought——”
“You thought I did not care,” said the boy. “And yet you had snatched
me from beneath the hoofs of a herd of cattle.”
“Which was no more than a fair return for the times that you kept Old
Joe from letting daylight through me.”
“Joe thought he would be doing me a favor; that was why he tried to
shoot you twice.”
“Merriwell,” said Carson, “it strikes me that you have your baseball-
team.”
“Right!” exclaimed Hodge. “Now we’ll take some of the conceit out of
the Denver Reds.”
“I have not played the game since I left you last year,” said
Swiftwing. “I shall be entirely out of practise.”
“We have time to get into practise some,” Merry explained. “We’ll try
to do so without delay. Where is the White Dove, Swiftwing?”
“She became tired of our life, far from the friends she had known,”
explained the young Indian. “It is not strange, for she has the blood
of the white man in her veins. I saw she was getting restless and
unhappy. At first she would not tell me why, but I discovered her
secret. Then I sent her back to Badger’s ranch, where she shall stay
till she wants to come to me again.”
“And you,” said Frank, smiling a little, “despite your resolve to
become a hermit and mingle no more with men, I rather fancy you
fell to longing for the excitement of the diamond and the tumult of the
gridiron. Is it not true, John?”
“Sometimes I think of it,” the young Indian confessed. “It is like
nothing else, and once a man has played the games and loved
them, he may never quite forget.”
“That’s the truth,” nodded Carson.
They took the elevator and went up to Merry’s room, Frank insisting
that Crowfoot should come along. Old Joe would not have
accompanied them, however, had not Dick urged him to do so.
“Smoke?” questioned the wrinkled Indian, as soon as he was inside
Merriwell’s handsomely furnished suite, which was one of the best in
the hotel.
“As much as you like,” nodded Merry, flinging wide open a window.
The old savage gravely squatted on the floor, bringing forth his long
black pipe and filling it with tobacco. When he had lighted it he sat
there, puffing away in silence, while the others talked.
Of course, there was much to talk about, and the conversation was
moving briskly when Ready and Rattleton drifted in. Jack struck a
pose when his eyes fell on Swiftwing.
“What is this I behold?” he cried dramatically. “Is it my noble friend of
the war-path? Whoop! It is! It are! It am! Come to me arms, my noble
ghost-dancer, and let me fold you, like a long-lost brother, in a fond
embrace.”
Then he pranced forward and clasped the hand which Swiftwing
gravely submitted. The young Indian was accustomed to the
exuberant ways of Ready, and took no offense.
“And here is that gentle young gazelle, Joseph Crowfoot, Esquire,”
said Ready, making a grand bow. “Chief, I salute you.”
“Ugh!” grunted Old Joe, as he continued smoking, without paying
any further attention to Jack.
Then Ready saw Carson, rubbed his eyes, looked again, pinched
himself, and exclaimed:
“Ho! ha! Also he! he! Likewise ho! ho! This is another jolly little
surprise. Here is me old side-partner, the cow-puncher! Pard, this is
a sight for lame eyes! You dear old maverick, how is your general
health?”
“It’s first-class, Ready,” laughed Berlin, as he shook hands with Jack.
“I don’t think it ever was better.”
“Isn’t that perfectly lovely!” gurgled Ready. “You have happened
along just in time to get into the round-up. In the words of the poet,
‘What, oh, what, is so jolly as the sight of a bosom friend whom you
can touch for a beautiful green bank-note?’ I may want to borrow a
dollar or ten to-morrow, Carson.”
“When did you gind this fang—I mean, find this gang?” asked
Rattleton of Frank.
“Swiftwing, Crowfoot, and Carson happened along,” Merry
explained. “It’s dead lucky for us, as we have been challenged by the
Denver Reds to play ball, and we were two men short.”
Rattleton had met Swiftwing, and he shook hands with the young
Indian, while Ready was chattering away to Carson. Then he
grasped the hand of the young college man.
Soon the door opened to admit Gamp, Browning, and Carker, who,
of course, were equally surprised.
“Gug-gug-gashfry!” laughed the New Hampshire youth. “This is just
like old tut-tut-times!”
“Trouble! trouble!” murmured Browning wearily. “I scent baseball in
the air, and that means my finish. I’ll melt and run into a grease-spot
during this hot weather.”
“Baseball, at best,” said Carker, “is a rather cruel sport in many
ways. It is the triumph of the weak over the strong, which is a sad
thing to contemplate under any circumstances.”
“Hush!” said Merriwell, lifting his hand. “Be still, everybody!”
They obeyed, and, after a moment, Rattleton asked:
“What is it?”
“I fancied I heard the rumble of Carker’s pet earthquake,” answered
Merry gravely.
Greg flushed, then exclaimed:
“That’s all right, Merry; but the time is coming when you will hear and
feel something more than a distant rumbling and a faint tremor. The
time is coming when——”
“Will—you—let—up!” shouted Greg’s college friends, in unison, and
the ardent young Socialist relapsed into despairing silence.
CHAPTER XXV.
THE NINE AT PRACTISE.